Tony Wang

Therapeutic Group Manager, PHARMAC

Tony has broad experience in pharmacy and the pharmaceutical industry in New Zealand, particularly with interactions between private corporations and government. His experience range from the quality use of medicines through to pharmaceutical regulation and funding.

Tony holds a Bachelors of Pharmacy, a post-graduate degree in Health Economics, and he is currently working towards a post-graduate Health Management degree. His research as a clinical pharmacist documenting the prescribing patterns of osteoporosis drugs within the hospital also won the New Zealand Hospital Pharmacist Associations poster award. Tony’s professional interests are in clinical pharmacy, health economics, health systems, and public health.

Tony started his career as a clinical pharmacist at Middlemore Hospital where he worked at the front-line of healthcare delivery. He then joined the New Zealand Ministry of Health to work in premarket approval where he assessed new medicines for efficacy, manufacturing quality, and safety.

Tony currently works as a health economist at PHARMAC where he conducts cost-benefit analysis on new healthcare technologies. His work enables New Zealanders to enjoy the best health outcomes reasonably achieved from pharmaceutical treatments, from within the funding that is available. Some of his work has received considerable media interest.

Tony believes that New Zealand being a small nation with a high level of transparency, visibility, and integrity, there are excellent opportunities ahead by increasing its connectedness with Asian countries and showcasing the best of what New Zealand has to offer. One way to do that is through leadership.

Tony was born in China and migrated to New Zealand when he was 6 years old. During his free time he enjoys a good coffee, reading, riding his motorbike, and diving.